Archives

  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Influenza Hemagglutinin (HA) Peptide: High-Purity Epitope...

    2026-03-23

    Influenza Hemagglutinin (HA) Peptide: High-Purity Epitope Tag for Protein Detection and Purification

    Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic, nine-amino acid reagent widely deployed as an epitope tag in molecular biology. (1) The HA tag enables antibody-based detection and purification of fusion proteins through competitive binding and elution mechanisms (APExBIO). (2) The A6004 product offers >98% purity confirmed by HPLC and mass spectrometry, ensuring consistent assay performance. (3) Its solubility in DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), and water (≥46.2 mg/mL) facilitates integration into diverse biochemical workflows. (4) The HA peptide is validated for immunoprecipitation assays, including exosome studies where precise protein tagging is required (Wei et al., 2021). (5) Proper storage at -20°C and minimal freeze-thaw cycles maximize reagent longevity and function.

    Biological Rationale

    The Influenza Hemagglutinin (HA) Peptide is derived from the hemagglutinin protein of human influenza virus, specifically from residues 98–106 (YPYDVPDYA) of the HA1 subunit. This epitope is recognized with high specificity by monoclonal antibodies, such as clone 12CA5, enabling selective detection and purification of HA-tagged proteins (APExBIO). The compact, linear sequence provides minimal steric hindrance when fused to target proteins, preserving native conformation and function. HA tagging has become a standard in molecular biology, facilitating studies of protein localization, protein-protein interactions, and post-translational modifications. Its use extends to exosome biology, viral infection research, and immunoassay development (see contrast: This article expands on the gold-standard status of the HA peptide by detailing competitive elution mechanisms and performance metrics).

    Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

    When expressed as a fusion tag, the HA peptide is presented on the surface of recombinant proteins. Anti-HA antibodies recognize the exposed epitope with high affinity, enabling efficient immunoprecipitation from complex lysates. In competitive elution protocols, synthetic HA peptide is added in excess. It binds to anti-HA antibodies, displacing the HA-tagged fusion protein via competitive inhibition. This process preserves protein integrity and function, as elution is achieved without harsh denaturants or extreme pH. The A6004 peptide from APExBIO is validated for these workflows, supporting high-recovery and low-background purification (contrast: This article extends strategic guidance on HA tag use by integrating recent advances in exosome sorting and translational research).

    Evidence & Benchmarks

    • High-purity synthetic HA peptide (>98%) ensures batch-to-batch reproducibility for protein detection and immunoprecipitation (APExBIO).
    • Solubility data: DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), and water (≥46.2 mg/mL), enabling flexible protocol integration (APExBIO).
    • HA peptide facilitates efficient competitive elution of HA-tagged proteins, preserving native structure and minimizing background (Wei et al., 2021, DOI).
    • Validated in exosome biogenesis studies to tag, track, and purify proteins of interest in complex biological contexts (Wei et al., 2021, DOI).
    • APExBIO’s A6004 peptide is confirmed by HPLC and mass spectrometry for research-grade applications (APExBIO).

    Applications, Limits & Misconceptions

    The HA peptide is employed in diverse workflows, including immunoprecipitation, western blotting, immunofluorescence, exosome isolation, and protein-protein interaction studies. Its compact size and high specificity make it a preferred tag for both mammalian and prokaryotic expression systems. In exosome research, the HA tag allows for sensitive tracking and enrichment of cargo proteins (contrast: This article focuses on next-generation HA tag applications in exosome biology, while the present dossier emphasizes benchmarks and practical integration). The peptide’s compatibility with widely available anti-HA antibodies ensures platform-agnostic use.

    Common Pitfalls or Misconceptions

    • The HA peptide does not facilitate purification without a compatible anti-HA antibody; direct affinity to other matrices is negligible.
    • Excessive freeze-thaw cycles or storage of peptide solutions for >1 week at 4°C can compromise activity; always store desiccated at -20°C.
    • Tagging may affect protein function if the epitope is inserted within structured domains or active sites—always verify tag placement.
    • HA peptide cannot substitute for other epitope tags (e.g., FLAG, Myc) without re-optimizing detection protocols.
    • False positives may arise from endogenous proteins sharing similar sequences; proper controls are essential.

    Workflow Integration & Parameters

    To utilize the Influenza Hemagglutinin (HA) Peptide (A6004), dissolve the lyophilized powder in DMSO, ethanol, or water at concentrations appropriate for your immunoprecipitation or competitive elution protocol (e.g., 1–2 mg/mL working stock). Store aliquots desiccated at -20°C, avoiding repeated freeze-thaw. For immunoprecipitation, add the peptide at a 10–20-fold molar excess over bound HA antibody to ensure efficient elution. The product’s high purity supports sensitive detection, and its validated performance in exosome and protein interaction studies aligns with workflows described in recent literature (contrast: This article updates protocol integration tips and decision-making guidance for reproducibility and optimization).

    Conclusion & Outlook

    The Influenza Hemagglutinin (HA) Peptide (A6004) from APExBIO is a rigorously validated, high-purity reagent supporting reliable protein tagging, immunoprecipitation, and molecular interaction studies. Its solubility, batch consistency, and compatibility with standard anti-HA antibodies make it the preferred epitope tag for modern biochemical research. Ongoing advances in exosome biology and translational workflows continue to expand its applications, as benchmarked in recent peer-reviewed studies (Wei et al., 2021). For further details and purchasing information, visit the APExBIO product page.